In this issue:
Budesonide-formoterol ‘as needed’ in mild asthma
Subcutaneous treprostinil for severe nonoperable CTREPH
Atomoxetine + oxybutynin treatment reduces OSA severity
Long-term mepolizumab data in severe eosinophilic asthma
Bioelectrical impedance analysis variables predict COPD outcomes
DOACs vs VKAs in extended anticoagulation for VTE
Mortality benefits of a β-lactam + macrolide in CAP
Corticosteroids + antibiotics: cost-effective in CAP
Increasing prevalence of AF in patients with end-stage COPD
Biomarkers linked to clinical outcomes in COPD
Please login below to download this issue (PDF)